Trial intelligence / Profile preview

Montelukast for Pediatric Asthma at School Start

NCT00461032Phase 3Completed

Sponsor
Organon & Co.
Start
Jun 2006
Primary completion
Nov 2006
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in asthma comparing Montelukast Arm with Placebo Arm (2 arms). Primary endpoint: Mean Percentage of Days With Worsening Asthma at 8 weeks. Started Jun 2006; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00461032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00461032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call